Trial Profile
A Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ONO-6950 in Healthy Adult Subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 15 Jun 2012
Price :
$35
*
At a glance
- Drugs Gemilukast (Primary)
- Indications Asthma
- Focus Adverse reactions
- 17 Jan 2012 Actual end date ( Oct 2011) added as reported by ClinicalTrials.gov.
- 17 Jan 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 01 Nov 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.